Literature DB >> 7827424

Waning immunity and its effects on vaccination schedules.

V Rouderfer1, N G Becker, H W Hethcote.   

Abstract

A relatively comprehensive age-specific transmission model is used to determine the effect of various factors on the optimal vaccination ages in one-dose and two-dose vaccination schedules. Motivated by the situation for measles, the model allows the duration of immunity of newborns to depend on the level of immunity of the mother at the time of the birth and allows for waning immunity as well as boosting of immunity by exposure to the disease. It is found that a significant amount of waning of disease-acquired immunity is plausible when boosting occurs but this is not an important factor in determining optimal vaccination schedules. On the other hand, plausible rates of loss of vaccine-induced immunity can have a substantial effect on the optimal vaccination schedule, particularly when there is no boosting of immunity. For two-dose schedules the optimal vaccination ages depend significantly on the level of vaccination coverage achieved. In the presence of plausible rates of loss of vaccine-induced immunity for measles, it is found that the vaccination coverage required to eradicate the disease is substantially higher than previously suggested.

Mesh:

Year:  1994        PMID: 7827424     DOI: 10.1016/0025-5564(94)90024-8

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  7 in total

1.  The evolutionary epidemiology of vaccination.

Authors:  Sylvain Gandon; Troy Day
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

2.  Implications of vaccination and waning immunity.

Authors:  J M Heffernan; M J Keeling
Journal:  Proc Biol Sci       Date:  2009-03-04       Impact factor: 5.349

3.  Immuno-epidemiology of a population structured by immune status: a mathematical study of waning immunity and immune system boosting.

Authors:  M V Barbarossa; G Röst
Journal:  J Math Biol       Date:  2015-04-02       Impact factor: 2.259

4.  Imperfect vaccine and hysteresis.

Authors:  Xingru Chen; Feng Fu
Journal:  Proc Biol Sci       Date:  2019-01-16       Impact factor: 5.349

5.  Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.

Authors:  Nele Goeyvaerts; Niel Hens; Marc Aerts; Philippe Beutels
Journal:  Biostatistics       Date:  2010-09-14       Impact factor: 5.899

6.  Modelling the effect of a booster vaccination on disease epidemiology.

Authors:  M E Alexander; S M Moghadas; P Rohani; A R Summers
Journal:  J Math Biol       Date:  2005-11-10       Impact factor: 2.164

7.  The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence.

Authors:  G S A Smit; S Abrams; P Dorny; N Speybroeck; B Devleesschauwer; V Hutse; H Jansens; H Theeten; P Beutels; N Hens
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.